Cargando…
Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions
Inflammatory bowel disease (IBD) is a chronic relapsing-remitting inflammatory disease of the gastrointestinal tract. Patients are usually diagnosed in adolescence and early adulthood and need lifelong treatment. In recent years, it has been found that diet plays an important role in the pathogenesi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207447/ https://www.ncbi.nlm.nih.gov/pubmed/35734374 http://dx.doi.org/10.3389/fnut.2022.794169 |
_version_ | 1784729533709025280 |
---|---|
author | Ban, Quan-Yao Liu, Mei Ding, Ning Chen, Ying Lin, Qiong Zha, Juan-Min He, Wei-Qi |
author_facet | Ban, Quan-Yao Liu, Mei Ding, Ning Chen, Ying Lin, Qiong Zha, Juan-Min He, Wei-Qi |
author_sort | Ban, Quan-Yao |
collection | PubMed |
description | Inflammatory bowel disease (IBD) is a chronic relapsing-remitting inflammatory disease of the gastrointestinal tract. Patients are usually diagnosed in adolescence and early adulthood and need lifelong treatment. In recent years, it has been found that diet plays an important role in the pathogenesis of IBD. Diet can change intestinal barrier function, affect the structure and function of intestinal flora, and promote immune disorder, thus promoting inflammation. Many patients believe that diet plays a role in the onset and treatment of the disease and changes their diet spontaneously. This review provides some insights into how nutraceuticals regulate intestinal immune homeostasis and improve intestinal barrier function. We reviewed the research results of dietary fiber, polyphenols, bioactive peptides, and other nutraceuticals in the prevention and treatment of IBD and sought better alternative or supplementary treatment methods for IBD patients. |
format | Online Article Text |
id | pubmed-9207447 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92074472022-06-21 Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions Ban, Quan-Yao Liu, Mei Ding, Ning Chen, Ying Lin, Qiong Zha, Juan-Min He, Wei-Qi Front Nutr Nutrition Inflammatory bowel disease (IBD) is a chronic relapsing-remitting inflammatory disease of the gastrointestinal tract. Patients are usually diagnosed in adolescence and early adulthood and need lifelong treatment. In recent years, it has been found that diet plays an important role in the pathogenesis of IBD. Diet can change intestinal barrier function, affect the structure and function of intestinal flora, and promote immune disorder, thus promoting inflammation. Many patients believe that diet plays a role in the onset and treatment of the disease and changes their diet spontaneously. This review provides some insights into how nutraceuticals regulate intestinal immune homeostasis and improve intestinal barrier function. We reviewed the research results of dietary fiber, polyphenols, bioactive peptides, and other nutraceuticals in the prevention and treatment of IBD and sought better alternative or supplementary treatment methods for IBD patients. Frontiers Media S.A. 2022-06-06 /pmc/articles/PMC9207447/ /pubmed/35734374 http://dx.doi.org/10.3389/fnut.2022.794169 Text en Copyright © 2022 Ban, Liu, Ding, Chen, Lin, Zha and He. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nutrition Ban, Quan-Yao Liu, Mei Ding, Ning Chen, Ying Lin, Qiong Zha, Juan-Min He, Wei-Qi Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions |
title | Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions |
title_full | Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions |
title_fullStr | Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions |
title_full_unstemmed | Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions |
title_short | Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions |
title_sort | nutraceuticals for the treatment of ibd: current progress and future directions |
topic | Nutrition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207447/ https://www.ncbi.nlm.nih.gov/pubmed/35734374 http://dx.doi.org/10.3389/fnut.2022.794169 |
work_keys_str_mv | AT banquanyao nutraceuticalsforthetreatmentofibdcurrentprogressandfuturedirections AT liumei nutraceuticalsforthetreatmentofibdcurrentprogressandfuturedirections AT dingning nutraceuticalsforthetreatmentofibdcurrentprogressandfuturedirections AT chenying nutraceuticalsforthetreatmentofibdcurrentprogressandfuturedirections AT linqiong nutraceuticalsforthetreatmentofibdcurrentprogressandfuturedirections AT zhajuanmin nutraceuticalsforthetreatmentofibdcurrentprogressandfuturedirections AT heweiqi nutraceuticalsforthetreatmentofibdcurrentprogressandfuturedirections |